Advertisement
U.S. Markets closed

Tourmaline Bio, Inc. (TRML)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
28.26-0.87 (-2.99%)
At close: 04:00PM EDT
29.50 +1.24 (+4.39%)
After hours: 07:39PM EDT
Advertisement
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
Total Revenue
0
0
0
Operating Expense
61,021
45,409
19,701
Operating Income
-61,021
-45,409
-19,701
Other Income Expense
11,730
3,285
-
Pretax Income
-49,291
-42,124
-19,701
Net Income Common Stockholders
-49,291
-42,124
-19,701
Diluted NI Available to Com Stockholders
-49,291
-42,124
-19,701
Basic EPS
-0.42
-8.87
-0.97
Diluted EPS
-0.42
-8.87
-0.97
Basic Average Shares
20,337
4,747
20,337
Diluted Average Shares
20,337
4,747
20,337
Total Operating Income as Reported
-61,021
-45,409
-19,701
Total Expenses
61,021
45,409
19,701
Net Income from Continuing & Discontinued Operation
-49,291
-42,124
-19,701
Normalized Income
-49,291
-42,124
-19,701
EBIT
-61,021
-45,409
-19,701
EBITDA
-60,981
-45,376
-19,695
Reconciled Depreciation
40
33
6
Net Income from Continuing Operation Net Minority Interest
-49,291
-42,124
-19,701
Normalized EBITDA
-60,981
-45,376
-19,695
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0